Majid Esmaelizad

Dr. Majid Esmaelizad

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

21 December 2016 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
MEMajid Esmaelizad
Majid Esmaelizad
VMVafa Mayahi
Vafa Mayahi
MPMaryam Pashaei
Maryam Pashaei
HGHossein Goudarzi
Hossein Goudarzi

29 August 2015 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
RTRoghayeh Teimourpour
Roghayeh Teimourpour
ASAli Sadeghian
Ali Sadeghian
ZMZahra Meshkat
Zahra Meshkat
MEMajid Esmaelizad
Majid Esmaelizad
MSMojtaba Sankian
Mojtaba Sankian
AJAhmad-Reza Jabbari
Ahmad-Reza Jabbari
Background: Tuberculosis (TB) is a contagious disease caused by Mycobacterium tuberculosis. Development of a new vaccine for tuberculosis requires immunogenic antigens capable of inducing suitable and long-lasting T cell immunity. The emergence of multidrugs and extensively drug-resistant strains of M. tuberculosis has made it a global public health concern. Objectives: DNA vaccine is a straightforward method to introduce antigens to the host. In the present study, two immunodominant mycobacterial antigens (Mtb32C and HBHA) were isolated and cloned into pcDNA3.1 (+) to design and construct a new DNA vaccine. This vector is capable of producing new potent chimeric protein. Materials and Methods: Mtb32C (Rv0125) and heparin-binding haemagglutinin adhesion (HBHA) genes were amplified using polymerase chain reaction (PCR) of M. tuberculosis H37Rv genome and ligated into pcDNA3.1 (+). Colony-PCR and restriction enzyme analysis were used to confirm the accuracy of the cloning procedure. Results: In the current study, recombinant pcDNA3.1 (+) vector containing Mtb32C and HBHA genes was successfully constructed. The desired size of DNA fragment was observed using single and double digestion methods. Conclusions: Mtb32C and HBHA genes were successfully isolated from H37Rv genome and cloned into an eukaryotic expression vector. This vector can be considered as a vaccine to evaluate immune responses in animal models. Keywords: Vaccines, DNA; HBHA protein; Mtb32 antigen; Mycobacterium tuberculosis

EDEbrahim Khodaverdi Darian
Ebrahim Khodaverdi Darian
MFMohammad Mahdi Forghanifard
Mohammad Mahdi Forghanifard
SBSoheila Moradi Bidhendi
Soheila Moradi Bidhendi
YCYung-Fu Chang
Yung-Fu Chang
EYEmad Yahaghi
Emad Yahaghi
PKPejvak Khaki
Pejvak Khaki
Cloning and Sequence Analysis of LipL32, a Surface–Exposed Lipoprotein of Pathogenic Leptospira Spp - Iranian Red Crescent Medical Journal - - Kowsar

11 June 2014 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
MDMEHRANGIZ DEZHBORD
MEHRANGIZ DEZHBORD
MEMajid Esmaelizad
Majid Esmaelizad
PKPejvak Khaki
Pejvak Khaki
FFFariba Fotohi
Fariba Fotohi
AMAthena Zarehparvar Moghaddam
Athena Zarehparvar Moghaddam
Leptospirosis, caused by infection with pathogenic Leptospira species, is one of the most prevalent zoonotic diseases in the world. Current leptospiral vaccines are mainly multivalent dead whole-cell mixtures made of several local dominant serovars. Therefore, design and construction of an efficient recombinant vaccine for leptospirosis control is very important. OmpL1 is an immunogenic porin protein that could be of special significance in vaccination and serodiagnosis for leptospirosis.

1 January 2017 in Acta Virologica
Verified
Journal Article
Closed access
VMV. Mayahi
V. Mayahi
MEMajid Esmaelizad
Majid Esmaelizad
Identification of novel E347Q and G362K amino acid substitutions in HN neutralization epitope and major antigenic difference in novel sub-genotype VIIj isolates